This article has Open Peer Review reports available.
Human and entomological surveillance of West Nile fever, dengue and chikungunya in Veneto Region, Italy, 2010-2012
- Federico Gobbi1Email author,
- Gioia Capelli2,
- Andrea Angheben1,
- Mario Giobbia3,
- Mario Conforto4,
- Marzia Franzetti5,
- Anna Maria Cattelan6,
- Enzo Raise7,
- Pierangelo Rovere8,
- Paolo Mulatti2,
- Fabrizio Montarsi2,
- Andrea Drago9,
- Luisa Barzon10, 11,
- Giuseppina Napoletano12,
- Francesca Zanella13,
- Francesca Pozza13,
- Francesca Russo13,
- Paolo Rosi14,
- Giorgio Palù10, 11,
- Zeno Bisoffi1 and
- Summer Fever Study Group
© Gobbi et al.; licensee BioMed Central Ltd. 2014
Received: 25 September 2013
Accepted: 30 January 2014
Published: 5 February 2014
Since 2010 Veneto region (North-Eastern Italy) planned a special integrated surveillance of summer fevers to promptly identify cases of West Nile Fever (WNF), dengue (DENV) and chikungunya (CHIKV). The objectives of this study were (i) To increase the detection rate of imported CHIKV and DENV cases in travellers from endemic areas and promptly identify potential autochthonous cases.(ii) To detect autochthonous cases of WNF, besides those of West Nile Neuroinvasive Disease (WNND) that were already included in a national surveillance.
Human surveillance: a traveler who had returned within the previous 15 days from endemic countries, with fever >38°C, absence of leucocytosis (leukocyte count <10,000 μL), and absence of other obvious causes of fever, after ruling out malaria, was considered a possible case of CHIKV or DENV. A possible autochthonous case of WNF was defined as a patient with fever >38°C for <7 days, no recent travel history and absence of other obvious causes of fever. Entomologic surveillance: for West Nile (WNV) it was carried out from May through November placing CDC-CO2 traps in five provinces of Veneto Region, while for DENV and CHIKV it was also performed around residences of viremic cases.
Human surveillance: between 2010 and 2012, 234 patients with fever after travelling were screened, of which 27 (11,5%) were found infected (24 with DENV and 3 with CHIKV). No autochthonous case of DENV or CHIKV was detected. Autochthonous patients screened for WNF were 408, and 24 (5,9%) were confirmed cases. Entomologic surveillance: the WNV was found in 10, 2 and 11 pools of Culex pipiens from 2010 to 2012 respectively, in sites of Rovigo, Verona, Venezia and Treviso provinces). No infected Aedes albopictus with DENV or CHIKV was found.
Veneto is the only Italian region reporting WNV human cases every year since 2008. WNV is likely to cause sporadic cases and unforeseeable outbreaks for decades. Including WNF in surveillance provides additional information and possibly an early alert system. Timely detection of DENV and CHIKV should prompt vector control measures to prevent local outbreaks.
In Italy, the first outbreak of West Nile virus (WNV) infection was reported in 1998 among horses residing in Tuscany region . The virus re-emerged in Italy in 2008, when equine and human cases of West Nile neuroinvasive disease (WNND) were notified in Veneto and Emilia Romagna Regions [2, 3].
Moreover, veterinary and entomological surveillance documented that WNV infection was widespread in the same areas in North-Eastern Italy, with notification of 251 outbreaks in equine stables and viral isolation in resident bird species .
Autochthonous cases of chikungunya (CHIKV) in Europe were reported in the well known outbreak in Emilia Romagna in 2007  and in France in 2010 . Autochthonous cases of dengue (DENV) in Europe were reported in 2010 in France [6, 7] and in Croatia [8, 9] while in 2012 a large outbreak occurred in the island of Madeira (Portugal) .
In view of the appearance of human WNV in our Region on one side, and of the established and massive presence of Ae. albopictus on the other, since 2010 Veneto Region (North-Eastern Italy) has planned a special integrated surveillance of summer fevers to promptly identify cases of West Nile Fever (WNF), DENV and CHIKV.
Cases of the three diseases notified in Veneto Region, 2008-2012
Imported dengue cases/patients screened
Imported chikungunya cases/patients screened
Autochthonous WNF cases/patients screened
Autochthonous WNND cases
In 2009 four cases of imported DENV and 6 cases of WNND (one fatal) had been reported , with no case of CHIKV nor of WNF.
The success of the pilot phase in 2010  prompted the Regional authorities to extend the project to two more years (2011-2012), as part of the integrated surveillance of arboviral diseases, along with veterinary and entomologic surveillance.
To increase the detection rate of imported CHIKV and DENV cases in travellers from endemic areas, including new immigrants and settled immigrants visiting relatives and friends (VFR), and to promptly identify potential autochthonous cases;
To detect autochthonous cases of WNF, along with those of WNND already included in regular surveillance, in order to obtain a more reliable picture of the disease transmission in the region.
To detect DENV or CHIKV in Ae. albopictus vectors, in case of the report of a viremic human case of DENV or CHIKV;
to predict the WNV circulation in the area through the search of the virus in Culex pipiens vectors.
If rapid tests for DENV or CHIKV resulted positive, the patient was considered a probable case. Rapid tests included detection of anti-CHIKV IgM with the OnSite Chikungunya IgM Combo Rapid Test (CTK Biotech, Inc., San Diego, CA, USA), anti-DENV IgM and IgG with the Dengue Quick test (Cypress Diagnostics, Langdorp, Belgium) and of DENV nonstructural protein (NS) 1 antigen with the Dengue NS1 Ag STRIP (Bio-Rad Laboratories, Hercules, CA, USA) on serum samples. Confirmed cases were defined as the presence of viral nucleic acid in blood specimens or by seroconversion or detection of increasing serum levels of specific IgM and IgG.
Second-line laboratory testing consisted of detection of DENV and CHIKV nucleic acids in plasma specimens by using real-time PCR and endpoint PCR, respectively, and detection of serum IgM and IgG by using an anti-CHIKV indirect immunofluorescence assay (Euroimmun AG, Lübeck, Germany), DENV IgG DxSelect (Focus Diagnostics, Cypress, CA, USA), and DENV IgM Capture DxSelect (Focus Diagnostics). Samples with DENV positive results by ELISA were further tested by plaque-reduction neutralization test to confirm specificity of antibody response.
A possible autochthonous case of WNF was defined as a patient with fever >38°C for <7 days, age >15 years, no recent travel history and absence of other obvious causes of fever.
A probable case was defined as a patient with a positive first-line laboratory test. The latter included detection of IgM and IgG antibodies against WNV in serum and CSF samples, with ELISA (WNV IgM capture DxSelect ELISA and IgG DxSelect ELISA kits, Focus Diagnostics, Cypress, California). A confirmed case was defined as a patient with at least one of the following laboratory criteria: isolation of WNV from blood; detection of WNV RNA by RT-PCR in blood; detection of increasing levels of IgM and IgG antibodies against WNV by ELISA, confirmed by plaque-reduction neutralisation test (PRNT).
Entomologic surveillance was also performed in areas surrounding the residence of human cases of DENV and CHIKV, if notified as viremic. In this case BG-sentinel traps with BG-Lure attractant (a mosquito attractant that mimics human skin odour) were used to capture adults of Ae. albopictus. Mosquitoes were counted, identified, frozen (-80°C) and sent to the National Arbovirus laboratory in Rome for virus examination.
The mean abundance of mosquitoes per traps was compared among years using analysis of variance (ANOVA), after loge(x + 1) transformation of the data. The rates of infection in mosquitoes were adjusted for pooled samples calculating the estimated rate of infection (ERI), according to Cowling et al. . For the 2012 season only, when a higher number of human cases was reported, the vector index was calculated for 2-week time steps by using abundance (numbers per trap per night) of the traps located in a radius of 25 km from the positive/s traps and ERI for Cx. pipiens mosquitoes . For the calculation of the vector index a trap of the neighbouring region (Friuli Venezia Giulia) was also included due to landscape homogeneity and trap proximity with human cases. The vector index was correlated with the human cases using linear regression. The software used was SPSS for Windows, version 13.0.
This paper describes the results of a surveillance program put in place by health authorities of the Region and was not primarily intended as a research project. For this reason a formal ethical clearance was not required. Patient data are fully anonimized and no specific activity on human subjects was undertaken, other than that planned as regular surveillance activity and patient clinical management according to usual practice.
Characteristic of DENV, CHIKV, WNF cases, diagnosed in Veneto Region between 15 th of June and 30 th of November, years 2010-2012
N° of cases
Mean age (range), years
Area of exposure
Time from symptom onset to diagnosis, (range) days
Positivity of PCR and/or viral isolation
Adm. to hospital
1 (5 cases)
2 (3 cases)
3 (5 cases)
CO 2 traps activated from 2010 to 2012 in Veneto region, mosquitoes collected, WNV positive pools and Estimated Rate of Infection (ERI)
Total no. of traps
Total mosquitoes collected
mean Cx pipiens/capture
WNV pos pools
WNV pos sites
The WNV was found in 10, 2 and 11 pools of Cx. pipiens from 2010 to 2012 respectively, in sites of Rovigo, Verona, Venezia and Treviso provinces (Figure 4), areas where viral circulation was known, on the basis of human and veterinary cases detected in the previous years.
Despite the drought, the year 2012 was characterized by a significantly higher abundance of Cx pipiens compared to the two previous years (Table 3).
In summary, during the three years period of the study we found 24 cases of DENV, 3 cases of CHIKV, 24 cases of WNF. All survived. The proportion over all subjects screened was 10.2% for DENV, 1.2% for CHIKV, 5.9% for WNF. While no Aedes albopictus adult was found infected with DENV or CHIKV, pools of Culex pipiens infected with WNV were found in 4 of the 7 provinces of the region.
The recent major outbreak of dengue in Madeira island (Portugal) , the previous local transmission of DENV documented in France [6, 7], in Croatia [8, 9] and the outbreak of CHIKV in Emilia Romagna in 2007  highlight the importance of surveillance of imported cases in order to prevent or limit local transmission.
It is of note that PCR resulted positive in 15/24 (62%) of DENV cases in our series (Table 2): early detection in humans (that also allowed the identification of the serotype) prompted, when/where indicated, entomologic surveillance for Ae. albopictus to test the adults for viral presence, although none resulted positive.
Veneto is the only Italian region that has reported WNV human cases every year since 2008. In the whole country the data aren’t homogeneous [19, 20]. The first human cases were reported in Veneto and in Emilia Romagna in 2008 [2, 3], although a retrospective study revealed a human case in Tuscany in 2007 .
In 2011 two more regions, Sardinia and Friuli-Venezia Giulia, reported WNND cases  and one region, Marche, reported a WNF case . If surveillance was limited to WNND, we would be completely unaware of the virus circulation in the latter region. Moreover the viral circulation had been documented to occur in many areas of Italy from North to South through retrospective screening of solid organ donors and through entomologic and veterinary surveillance .
Based on our findings, we suggest that surveillance should also include WNF in order to provide additional information on the viral circulation in humans and contribute to an early alert system.
Before the special surveillance, in two years time since the beginning of the outbreak of autochthonous WNV disease, only one retrospective case of WNF had been reported, in spite of the expected proportion WNF/WNND of 20/1, according to the literature . It is worth noting that recent studies [25, 26] suggest that the proportion of symptomatic patients is even higher than previously reported . WNF is therefore the most common clinical presentation of West Nile disease, although many WNF cases remain undiagnosed. Patients with “simple” WNF should be monitored clinically to avoid the onset of complications, also remembering that WNF cases not evolving in WNND aren’t necessarily benign . Moreover the epidemiology of WNV transmission is unpredictable. In United States in 2012, the largest outbreak ever recorded was observed, after years of relative quiescence. Petersen and Fischer consider WNV “unpredictable, disagreeable and difficult to control”, suggesting that “WNV will cause sporadic cases and big and small unforeseeable outbreaks for decades to come” . For this reason they recommend a timely surveillance on a large scale in animals, insects and people.
In Veneto the entomological surveillance was useful (i) to define the mosquito species composition and relative density all over the region, indicating the area at major risk of WNV life cycle amplification, which are the main targets of the control strategies and (ii) to indicate Cx. pipiens as the main vector of WNV in this area.
The vector index showed to be correlated with the increasing number of human cases, indicating that it can be used as a predictor of clusters of cases in the surrounding areas within two weeks. However sporadic cases in humans (WNF and asymptomatic blood donors) have preceded detection in mosquitoes (Figure 5).
A clear vector index threshold was not identified and more data are needed before drawing any conclusion. In this respect, a more intensive entomological surveillance on a 1-week step has been scheduled for the next mosquito season in the area where the majority of human cases have been reported.
Interestingly, the 2012 upsurge of WNV human cases was found in a year characterized by a strong drought, which did not cause a decrease of mosquito population, likely due to the artificial irrigation in this area strongly devoted to corn production. The concentration of larval breeding sites closer to human settlement caused by the irrigation and the contemporary presence of synantropic birds able to act as reservoir of WNV may have caused an increased contact between humans and infected mosquitoes.
The major strengths of this surveillance project are the good integration of human and entomologic surveillance and the ability to provide a sufficiently comprehensive picture of the occurrence of these three arboviruses of human interest in our region.
The project had some limitations, too. A major weakness is the low number of WNF cases compared to WNND. The main reason is that most mild cases do not seek medical advice and, if they do, are seldom referred to hospital or to a laboratory. The cases detected are therefore the tip of the iceberg and, not surprisingly, were almost all admitted. Also, the total number of febrile patients returning from endemic countries and screened for DENV and CHIKV is comparatively low. Moreover, as most of them come from countries where malaria also occurs, it is clear that all these patients should promptly referred to skilled diagnosis, which is not always the case. In order to deal with both weaknesses, a better involvement of family doctors in surveillance is clearly crucial.
Future research should focus on the sustainability of this surveillance program, including a thorough cost analysis, in order to be able to recommend its adoption as a routine surveillance system and its diffusion to other regions.
WNV is likely to cause sporadic cases and unforeseeable outbreaks for decades. Including WNF in regular surveillance provides a more comprehensive picture of WNV circulation in humans. Timely detection of DENV and CHIKV should prompt vector control measures and contribute to prevent local outbreaks.
Other members of the Summer Fever Study Group: Ercole Concia, Ermenegildo Francavilla, Franco Marranconi, Giampietro Pellizzer, Piergiorgio Scotton, Dino Sgarabotto, Pierluigi Brugnaro, Paola Del Bravo, Roberto Ferretto, Giulia Masini, Valeria Mondardini, Filippo Viviani, Cinzia Piovesan, Chiara Postiglione, Margherita Cattai, Antonio Conti, Riccardo Cusinato, Monica Degani, Andrea Forti, Elisa Franchin, Massimo Gion, Roberto Marcante, Eliana Modolo, Monia Pacenti, Mario Rassu, Roberto Rigoli, Marino Scarin, Elisabetta Tonolli.
- Autorino GL, Battisti A, Deubel V, Ferrari G, Forletta R, Giovannini A, Lelli R, Murri S, Scicluna MT: West Nile virus epidemic in horses, Tuscany region, Italy. Emerg Infect Dis. 2002, 8 (12): 1372-1378. 10.3201/eid0812.020234.View ArticlePubMedPubMed CentralGoogle Scholar
- Rossini G, Cavrini F, Pierro A, Macini P, Finarelli A, Po C, Peroni G, Di Caro A, Capobianchi M, Nicoletti L, et al: First human case of West Nile virus neuroinvasive infection in Italy, September 2008 - case report. Euro Surveill. 2008, 13: 41-Google Scholar
- Barzon L, Squarzon L, Cattai M, Franchin E, Pagni S, Cusinato R, Palu G: West Nile virus infection in Veneto region, Italy, 2008-2009. Euro Surveill. 2009, 14: 31-Google Scholar
- Calistri P, Giovannini A, Hubalek Z, Ionescu A, Monaco F, Savini G, Lelli R: Epidemiology of west nile in europe and in the mediterranean basin. Open Virol J. 2010, 4: 29-37.PubMedPubMed CentralGoogle Scholar
- Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli AC, Panning M, Cordioli P, Fortuna C, Boros S, Magurano F, et al: Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet. 2007, 370 (9602): 1840-1846. 10.1016/S0140-6736(07)61779-6.View ArticlePubMedGoogle Scholar
- Gould EA, Gallian P, De Lamballerie X, Charrel RN: First cases of autochthonous dengue fever and chikungunya fever in France: from bad dream to reality!. Clin Microbiol Infect. 2010, 16 (12): 1702-1704. 10.1111/j.1469-0691.2010.03386.x.View ArticlePubMedGoogle Scholar
- La Ruche G, Souares Y, Armengaud A, Peloux-Petiot F, Delaunay P, Despres P, Lenglet A, Jourdain F, Leparc-Goffart I, Charlet F, et al: First two autochthonous dengue virus infections in metropolitan France, September 2010. Euro Surveill. 2010, 15 (39): 19676-PubMedGoogle Scholar
- Schmidt-Chanasit J, Haditsch M, Schoneberg I, Gunther S, Stark K, Frank C: Dengue virus infection in a traveller returning from Croatia to Germany. Euro Surveill. 2010, 15: 40-Google Scholar
- Gjenero-Margan I, Aleraj B, Krajcar D, Lesnikar V, Klobucar A, Pem-Novosel I, Kurecic-Filipovic S, Komparak S, Martic R, Duricic S, et al: Autochthonous dengue fever in Croatia, August-September 2010. Euro Surveill. 2011, 16: 9-Google Scholar
- Sousa CA, Clairouin M, Seixas G, Viveiros B, Novo MT, Silva AC, Escoval MT, Economopoulou A: Ongoing outbreak of dengue type 1 in the Autonomous Region of Madeira, Portugal: preliminary report. Euro Surveill. 2012, 17: 49-Google Scholar
- Sabatini A, Raineri V, Trovato G, Coluzzi M: [Aedes albopictus in Italy and possible diffusion of the species into the Mediterranean area]. Parassitologia. 1990, 32 (3): 301-304.PubMedGoogle Scholar
- Dalla Pozza G, Majori G: First record of Aedes albopictus establishment in Italy. J Am Mosq Control Assoc. 1992, 8 (3): 318-320.PubMedGoogle Scholar
- Gobbi F, Napoletano G, Piovesan C, Russo F, Angheben A, Rossanese A, Cattelan AM, Gallo L, Valsecchi M, Piazza A, et al: Where is West Nile fever? Lessons learnt from recent human cases in northern Italy. Euro Surveill. 2009, 14: 10-Google Scholar
- Rizzo C, Vescio F, Declich S, Finarelli AC, Macini P, Mattivi A, Rossini G, Piovesan C, Barzon L, Palu G, et al: West Nile virus transmission with human cases in Italy, August - September 2009. Euro Surveill. 2009, 14: 40-Google Scholar
- Gobbi F, Barzon L, Capelli G, Angheben A, Pacenti M, Napoletano G, Piovesan C, Montarsi F, Martini S, Rigoli R, et al: Surveillance for West Nile, dengue, and chikungunya virus infections, Veneto Region, Italy, 2010. Emerg Infect Dis. 2012, 18 (4): 671-673.View ArticlePubMedPubMed CentralGoogle Scholar
- Ravagnan S, Granato A, Porcellato E, Cazzin S, De Nardi R, Mazzacan E: Development of a One-Step Real-Time PCR Assay for detection of Flaviviruses in pooled mosquitoes. 5th Annual Meeting EPIZONE. 2011Google Scholar
- Cowling DW, Gardner IA, Johnson WO: Comparison of methods for estimation of individual-level prevalence based on pooled samples. Prev Vet Med. 1999, 39 (3): 211-225. 10.1016/S0167-5877(98)00131-7.View ArticlePubMedGoogle Scholar
- Kwan JL, Park BK, Carpenter TE, Ngo V, Civen R, Reisen WK: Comparison of enzootic risk measures for predicting West Nile disease, Los Angeles, California, USA, 2004-2010. Emerg Infect Dis. 2012, 18 (8): 1298-1306.View ArticlePubMedPubMed CentralGoogle Scholar
- Rizzo C, Salcuni P, Nicoletti L, Ciufolini MG, Russo F, Masala R, Frongia O, Finarelli AC, Gramegna M, Gallo L, et al: Epidemiological surveillance of West Nile neuroinvasive diseases in Italy, 2008 to 2011. Euro Surveill. 2012, 17: 20-Google Scholar
- Sanità IS: Sorveglianza dei casi umani di malattia neuro invasiva da West Nile Virus. 2012Google Scholar
- Cusi MG, Roggi A, Terrosi C, Gori Savellini G, Toti M: Retrospective diagnosis of West Nile virus infection in a patient with meningoencephalitis in Tuscany, Italy. Vector Borne Zoonotic Dis. 2011, 11 (11): 1511-1512. 10.1089/vbz.2010.0248.View ArticlePubMedGoogle Scholar
- Bagnarelli P, Marinelli K, Trotta D, Monachetti A, Tavio M, Del Gobbo R, Capobianchi M, Menzo S, Nicoletti L, Magurano F, et al: Human case of autochthonous West Nile virus lineage 2 infection in Italy, September 2011. Euro Surveill. 2011, 16: 43-Google Scholar
- Capobianchi MR, Sambri V, Castilletti C, Pierro AM, Rossini G, Gaibani P, Cavrini F, Selleri M, Meschi S, Lapa D, et al: Retrospective screening of solid organ donors in Italy, 2009, reveals unpredicted circulation of West Nile virus. Euro Surveill. 2010, 15: 34-Google Scholar
- Hayes EB, Sejvar JJ, Zaki SR, Lanciotti RS, Bode AV, Campbell GL: Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis. 2005, 11 (8): 1174-1179. 10.3201/eid1108.050289b.View ArticlePubMedPubMed CentralGoogle Scholar
- Zou S, Foster GA, Dodd RY, Petersen LR, Stramer SL: West Nile fever characteristics among viremic persons identified through blood donor screening. J Infect Dis. 2010, 202 (9): 1354-1361. 10.1086/656602.View ArticlePubMedGoogle Scholar
- Carson PJ, Borchardt SM, Custer B, Prince HE, Dunn-Williams J, Winkelman V, Tobler L, Biggerstaff BJ, Lanciotti R, Petersen LR, et al: Neuroinvasive disease and West Nile virus infection, North Dakota, USA, 1999-2008. Emerg Infect Dis. 2012, 18 (4): 684-686. 10.3201/eid1804.111313.View ArticlePubMedPubMed CentralGoogle Scholar
- Watson JT, Pertel PE, Jones RC, Siston AM, Paul WS, Austin CC, Gerber SI: Clinical characteristics and functional outcomes of West Nile Fever. Ann Intern Med. 2004, 141 (5): 360-365. 10.7326/0003-4819-141-5-200409070-00010.View ArticlePubMedGoogle Scholar
- Petersen LR, Fischer M: Unpredictable and difficult to control--the adolescence of West Nile virus. N Engl J Med. 2012, 367 (14): 1281-1284. 10.1056/NEJMp1210537.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/14/60/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.